GSK subsidiary TESARO sues AnaptysBio over cancer drug licensing dispute November 20, 2025November 20, 2025 · Business · By ReportWire GSK subsidiary TESARO sues AnaptysBio over cancer drug licensing dispute Investing.com Source link